MCHALE DUNCAN (Chief Medical Officer) sold 40.6% of their position (66.73K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $8.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/10/2023ACC: 0001694665-23-000054
Officer· Chief Medical Officer
Since Jan 2020
-66.73K
Net shares
Net seller
$8.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
66.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−66.73K
Price / share
$0.13
Trade value
$8.37K
% of position
40.6%
5/8/2023
164.25K→97.52K
Total
Net shares
−66.73K
Net value
-$8.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2023 | S · Sale | −66.73K | $0.13 | $8.37K | 40.6% | 164.25K | 97.52K |
| Total | −66.73K | -$8.37K | ||||||
Derivative Transactions0
No derivative transactions reported